Mirati Therapeutics, Inc.

NJ · United States · Reporting entity ID 100001376985

Total reported 2019–2025

$100.6M

#97 of 2,960 reporting companies — 0.1% of all reported industry payments

$2.03M in general payments across 15,648 records, plus $98.6M in research funding across 11,952 records.

How it breaks down

General payments $2,031,675

Research funding $98,595,864

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.